Qatar Investment Authority - Nov 25, 2024 Form SCHEDULE 13G Schedule Report for BioXcel Therapeutics, Inc. (BTAI)

Filing Manager: Qatar Investment Authority
Reporting Manager: Qatar Investment Authority
Security: BioXcel Therapeutics, Inc. Common Stock, par value $0.001
Symbol: BTAI
Shares outstanding: 52.4M shares
Disclosed Ownership: 2.72M shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Date filed: 12/18/2024, 05:20 PM
Date of event: Nov 25, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Qatar Investment Authority	5.2%	2.72M	2.72M	0	/s/ Andrew Watkins	Andrew Watkins**/Associate General Counsel, Head of Compliance